Terms: = Colorectal cancer AND BCL7A, BCL7, 605, ENSG00000110987 AND Clinical Outcome
3 results:
1. Validity and clinical impact of glucose transporter 1 expression in colorectal cancer.
GabAllah GMK; El-Din Habib MS; Soliman SE; Kasemy ZA; Gohar SF
Saudi J Gastroenterol; 2017; 23(6):348-356. PubMed ID: 29205188
[TBL] [Abstract] [Full Text] [Related]
2. Indeterminate but Likely Unimportant Extracolonic Findings at Screening CT Colonography (C-RADS Category E3): Incidence and outcomes Data From a clinical Screening Program.
Pooler BD; Kim DH; Pickhardt PJ
AJR Am J Roentgenol; 2016 Nov; 207(5):996-1001. PubMed ID: 27505184
[TBL] [Abstract] [Full Text] [Related]
3. Physical activity, tumor PTGS2 expression, and survival in patients with colorectal cancer.
Yamauchi M; Lochhead P; Imamura Y; Kuchiba A; Liao X; Qian ZR; Nishihara R; Morikawa T; Shima K; Wu K; Giovannucci E; Meyerhardt JA; Fuchs CS; Chan AT; Ogino S
Cancer Epidemiol Biomarkers Prev; 2013 Jun; 22(6):1142-52. PubMed ID: 23629521
[TBL] [Abstract] [Full Text] [Related]
